EGF and breast cancer: Furthermore, versican could influence cell proliferation by acting as a mitogen itself through the epidermal growth factor (EGF) sequences in the G3 domain [30,32], whereas versican G3 domain appears to be important in local and systemic tumor invasiveness of human breast cancer affecting both tumor cell survival and spread but also angiogenesis [49].